Canadian biotech company Mara Renewables, which produces fish-free Omega-3 derived from microalgae for health-conscious businesses seeking sustainable solutions, has raised USD$9.1 million. The company will use the funds support its expansion of its sustainable omega‑3 platform, deepen R&D capacity, and further scale its ability to address critical gaps across global nutrition supply chains.
Omega‑3 DHA has been scientifically proven to support cognitive function, vision, cardiovascular performance, and prenatal development. Some research shows 85% of the global population remains deficient in omega‑3. The nutrient is traditionally sourced from wild-caught fish at the end of the marine food chain.
Biochemistry company Mara offers a fish-free alternative that avoids reliance on vulnerable marine ecosystems and is derived from microalgae, at the beginning of the food chain. Mara uses fermentation to enable microalgae to grow in controlled environments. The company said that in 2024, it supplied enough algal DHA to offset an estimated 6.7 billion anchovies from the supply chain.
The funding came from S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans, and energy.
“In our view, Mara is solving a fundamental supply chain challenge with precision and scale,” said Larsen Mettler, Managing Director of S2G’s oceans strategy. “They have built an end-to-end platform that delivers consistent, clean, and high-quality omega-3s without relying on depleted fisheries.”
